欧盟评估裂殖壶菌（菌株ATCC-20889）油用于婴儿及较大婴儿配方食品中的安全性

核心提示：2025年1月22日，据欧盟食品安全局（EFSA）消息，欧盟营养、新型食品和食物过敏原（NDA）研究小组就裂殖壶菌油（oil from Schizochytrium limacinum (strain ATCC-20889)）作为新型食品用于婴儿及较大婴儿配方食品中的安全性发表科学意见。……（世界食品网-www.shijieshipin.com）

2025年1月22日，据欧盟食品安全局（EFSA）消息，欧盟营养、新型食品和食物过敏原（NDA）研究小组就裂殖壶菌油（oil from Schizochytrium limacinum (strain ATCC-20889)）作为新型食品用于婴儿及较大婴儿配方食品中的安全性发表科学意见。
经过评估，专家小组得出结论，在建议的使用条件下，裂殖壶菌（菌株ATCC-20889）油作为新型食品用于婴儿及较大婴儿配方食品中是安全的。部分原文报道如下：
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of an oil derived from the microalga Schizochytrium sp. (strain ATCC-20889) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a mixture of triglycerides in which docosahexaenoic acid (DHA) represents 40%–43% of fatty acids. The available evidence indicates that the source organism (strain ATCC-20889) belongs to the species Schizochytrium limacinum. The applicant intends to market the NF as an ingredient in infant formulae (IF) and follow-on formulae (FOF). The use levels proposed by the applicant were derived from Regulation (EU) 2016/127, which states the mandatory presence of DHA to IF and FOF at the levels of 20–50 mg/100 kcal. Schizochytrium limacinum was attributed the qualified presumption of safety (QPS) status with the qualification ‘for production purposes only’. Data provided by the applicant demonstrated the absence of viable cells in the NF. No toxicological studies were performed with the NF. However, based on the available toxicological data on oils derived from Schizochytrium sp., the QPS status of the source of the NF, the production process, the composition of the NF, the absence of marine biotoxins and viable cells in the NF, the Panel considers that there are no concerns with regard to the toxicity of the NF. The Panel concludes that the NF is safe under the proposed conditions of use.